Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 1, 2008, Pages 65-72

  Stang, Andrea ^a   Stausberg, J ^b   Boedeker, W ^c   Kerek Bodden, H ^d   Jockel K H ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c BKK Bundesverband   (Germany)

^d Central Research Institute of Ambulatory Health Care in Germany   (Germany)

Author keywords

Germany; Hospital costs; Hospitalization; Lengthof stay; Skin neoplasms

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; FEMALE; GENDER BIAS; GERMANY; HOSPITALIZATION COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SKIN CANCER; STANDARDIZATION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HEALTH CARE SURVEYS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; SKIN NEOPLASMS;

EID: 37849013626     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02334.x     Document Type: Article

References (26)

1. Weinstock MA. Epidemiology of nonmelanoma skin cancer: Clinical issues, definitions, and classification. J Invest Dermatol 1994; 102: 4S-5S.
2. Boyle P, Doré JF, Autier P, Ringborg U. Cancer of the skin: A forgotten problem in Europe. Ann Oncol 2004; 15: 5-6.
3. Fears TR, Scotto J. Changes in skin cancer morbidity between 1971-72 and 1977-78. J Natl Cancer Inst 1982; 69: 365-370.
4. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17.
5. Green A, Battistutta D. Incidence and determinants of skin cancer in a high risk Australian population. Int J Cancer 1990; 46: 356-361.
6. Roberts DL. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990; 122: 399-403.
7. Kricker A, English DR, Randell PL et al. Skin cancer in Geraldton, Western Australia: A survey of incidence and prevalence. Med J Aust 1990; 152: 399-407.
8. Serrano H, Scotto J, Shornick G, Fears TR, Greenberg ER. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont. J Am Acad Dermatol 1991; 24: 574-579.
9. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: Incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996; 144: 1034-1040.
10. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135: 781-786.
11. Levi F, Te VC, Randimbison L, Erler G, La Vecchia C. Trends in skin cancer incidence in Vaud: An update, 1976-1998. Eur J Cancer Prev 2001; 10: 371-373.
12. Stang A, Stegmaier C, Jöckel KH. Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995-1999. Br J Cancer 2003; 89: 1205-1209.
13. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: Incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149: 1200-1206.
14. Stang A, Ziegler S, Büchner U, Jöckel KH, Ziegler V. Malignant melanoma and non-melanoma skin cancers in Northrhine-Westphalia, Germany: A patient versus diagnosis-based incidence approach. Int J Dermatol 2007; 46: 564-570.
15. Stang A, Jöckel KH. Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968 through 1999. Br J Dermatol 2004; 150: 517-522.
16. Statistisches Bundesamt. Qualitätsbericht. Diagnosen der Krankenhauspatienten Statistisches Bundesamt, Wiesbaden, 2005.
17. Institut für das Entgeltsystem im Krankenhaus (InEK). Abschlussbericht. Weiterentwicklung des G-DRG-Systems für das Jahr. InEK, Siegburg, 2004.
18. Kerek-Bodden H, Heuer J, Brenner G et al. Morbiditäts-und Inanspruchnahmeanalysen mit personenbezogenen Abrechnungsdaten aus Arztpraxen. In: Swart E, Ihle P, eds. Routinedaten Im Gesundheitswesen. Hans Huber Verlag, Bern, 2005: 35-55.
19. SAS Institute. SAS for Windows, Version 9.1. Cary, NC, USA, 2002.
20. Stang A, Stang K, Stegmaier C, Hakulinen T, Jöckel KH. Skin melanoma in Saarland: Incidence, survival and mortality 1970-1996. Eur J Cancer Prev 2001; 10: 407-415.
21. Statistisches Bundesamt (Hrsg.). Kosten nach Krankheitsarten. Kurzfassung. Gesundheitsberichterstattung Des Bundes, Wiesbaden, 2000.
22. Gesundheitsberichtserstattung des Bundes. Krankheitskosten. 18th December 2006. http://www.gbe-bund.de.
23. Mathers C, Penm R, Sanson-Fisher R et al. Health system costs of cancer in Australia 1993-94. AIHW cat. no. HWE 8. Health and Welfare Expenditure Series, no. 4. Australian Institute of Health and Welfare and National Cancer Control Initiative, Canberra, 1998.
24. Housman TS, Feldman SR, Williford PM et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-429.
25. Breitbart EW, Wende A, Mohr P et al. Hautkrebs. Gesundheitsberichtserstattung des Bundes. Heft 22. Robert Koch-Institut, Berlin, 2004,.
26. Brown ML, Hodgson TA, Rice DP. Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd edn. Oxford University Press, New York, 1996.